Salute e Benessere

Osteotec re-launches Silicone Finger Implant into UK and international markets

The Osteotec Silicone Finger Implant has remained available and widely used in FDA markets, and the reintroduction of CE certification is expected to drive global sales and increase access to the product for surgeons worldwide. The Osteotec Silicone Finger Implant has remained available and widely used in FDA markets, and the reintroduction of CE certification is expected to drive global sales and increase access to the product for surgeons worldwide. The one-piece, sterile, flexible...
PR Newswire
09/12/2024

Surgical Gloves Market Size Estimated to be Worth US$ 7.43 Billion by 2031…

The report from The Insight Partners provides several stakeholders—including product manufacturers, physicians, patients, and end users—with valuable insights into how to successfully navigate this evolving market landscape and unlock new opportunities. The report from The Insight Partners provides several stakeholders—including product manufacturers, physicians, patients, and end users—with valuable insights into how to successfully navigate this evolving market landscape and unlock new…
PR Newswire
09/12/2024

Ovo-Sexing Technology Market Size Estimated to be Worth USD 105.848 Mn by 2031…

The report from The Insight Partners, therefore, provides several stakeholders—including pharmaceutical companies, biotechnology companies, poultry companies, equipment suppliers, and others—with valuable insights into how to successfully navigate this evolving market landscape and unlock new opportunities. The report from The Insight Partners, therefore, provides several stakeholders—including pharmaceutical companies, biotechnology companies, poultry companies, equipment suppliers, and...
PR Newswire
09/12/2024

Novo Nordisk A/S - share repurchase programme

Bagsværd, Denmark, 9 December 2024– On 11 November 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month period beginning 6 February 2024.Under…
Nasdaq GlobeNewswire
09/12/2024

Monica Lewinsky Visits Agnivesh Agarwal's Primeks Medical in Istanbul

Lewinsky toured Primeks Medical's state-of-the-art pathology lab, Istanbul Laboratories, export facilities of premium medical products and actively run wellness programs, as well as Estpoint aesthetic clinics in Istanbul. She praised the facilities for their innovative health technologies and advanced diagnostic capabilities, which are significant advancements, adding to Turkey's increasing prominence in health tourism.Monica Lewinsky is an advocate, writer, producer and public speaker...
Nasdaq GlobeNewswire
09/12/2024

Artificial Intelligence in Medical Diagnostics Market to Hit USD 4.72 Billion by…

Browse in-depth TOC on "Artificial Intelligence in Medical Diagnostics Market" Browse in-depth TOC on "Artificial Intelligence in Medical Diagnostics Market" 744 - Tables61 - Figures549 - Pages Based on components,AI in the medical diagnostics market is divided into software, services, and hardware. In 2023, the software segment dominated the market, while the services segment is estimated to grow at a higher CAGR from 2023-2029. The software segment dominates AI in...
PR Newswire
09/12/2024

Medical Second Opinion Market Surges to USD 15.40 Billion by 2031, Propelled by…

Growing emphasis on better treatment outcomes expected to determine the market growth in the coming years. The report runs an in-depth analysis of market trends, key players, and future opportunities. Growing emphasis on better treatment outcomes expected to determine the market growth in the coming years. The report runs an in-depth analysis of market trends, key players, and future opportunities. The report from The Insight Partners lists several stakeholders—including healthcare...
PR Newswire
09/12/2024

Home Appliances Market Surges to USD 1,344.47 Billion by 2030, Propelled by…

The Home Appliances Market covers a wide range of devices designed to simplify household tasks, including cooking, cleaning, and home comfort. Driven by urbanization, rising disposable incomes, and technological advancements, the market is shifting towards energy-efficient and smart appliances. Trends such as IoT integration, sustainability, and compact designs cater to evolving consumer needs. Key players focus on innovation to enhance convenience, performance, and user experience. TheHome...
PR Newswire
09/12/2024

TraceLink Successfully Completes Industry-Leading Audits: ISO/IEC 27001:2022…

These industry-leading compliance benchmarks assure customers that their supply chain data is safeguarded by the highest international standards. By maintaining robust security measures across its OPUS (Orchestration Platform for Universal Solutions) and cloud environments, TraceLink enables customers and their supply chain trading partners to focus on driving business growth with the confidence that their information is secure, compliant, and protected from evolving cyber threats. These...
PR Newswire
09/12/2024

Zero Candida Receives South African Patent for its ZC- 01 device

Zero-Candida T technologies, Inc. (ZCT) is FemTech developing an AI smart tampon-like device based on a therapeutic light source with a selected wave-length and intensity that can treat the Candida fungus successfully of 99.999% an POC overnight. Vulvo-Vaginal Candidiasis ("VVC") affects about 75% of women globally, and ZCT's device is game changer that has the potential to change the treatment of women and the FemTech industry in the world. The first of its kind of technology using…
PR Newswire
09/12/2024

Dreame launches exclusive Christmas deals with up to £400 off

Dreame X40 Ultra Complete (Was £1,299, now £899) Dreame X40 Ultra Complete (Was £1,299, now £899) The X40 Ultra Complete offers exceptional cleaning efficiency in even the tightest spaces around the home. With Dreame's MopExtend™ RoboSwing Technology and extendable side brush, the robot vacuum can remove dirt from under low furniture and in hard-to-reach corners, as deep as 4cm. It also has 12,000Pa Vormax™ Suction, swiftly lifting debris with fewer passes on hard floors and...
PR Newswire
09/12/2024

Phastar Scoops Prestigious 2024 Scrip Award

Phastar's dynamic Clinical Intelligence Portal was fundamental in securing the award, demonstrating advanced data visualization and analytics techniques that transform data into actionable insights. As a certified B Corporation®, Phastar illustrated how they support their environment, social, and governance (ESG) goals through SBTi Net-Zero targets, its Phastar Cares pro-bono scheme and staff volunteering program. Phastar's dynamic Clinical Intelligence Portal was fundamental in securing the...
PR Newswire
09/12/2024

Seoul National University Bundang Hospital Establishes the first "International…

The signing ceremony took place at 11 a.m. in the main conference room of Seoul National University Bundang Hospital, attended by key figures including Dr. Junghan Song, President & CEO of SNUBH; Professor Sanghoon Jheon; Dr. Kristophe Diaz, Executive Director & CSO of CurePSP; and Mr. Sukjoon Lee, CEO of GemVax. The signing ceremony took place at11 a.m.in the main conference room of SeoulNational UniversityBundang Hospital, attended by key figures including Dr.Junghan Song,...
PR Newswire
09/12/2024

Laboratory Information Systems (LIS) Market Forecast: Growth from USD 2.3…

IMR
09/12/2024

Primary Cells Market Forecast: Expected Growth from USD 1.6 Billion in 2023 to…

IMR
09/12/2024

Evaxion announces 2025 milestones reflecting continued strong strategy execution

With most of Evaxion's strategic milestones for 2024 now successfully achieved, the company announces milestones for 2025The 2025 key milestones reflect all parts of Evaxion's strategy for value realizationEvaxion expects to discuss the milestones at an investor event in the first quarter of 2025COPENHAGEN, Denmark, December 9, 2024 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines,...
Nasdaq GlobeNewswire
09/12/2024

Major shareholder announcement – AIM International Mutual Funds

ANNOUNCEMENT NO. 287 9 December 2024Major shareholder announcementMajor shareholder announcement – AIM International Mutual Funds Pursuant to Section 30 of the Capital Markets Act, it is hereby announced that Invesco Ltd. has informed ChemoMetec A/S that AIM International Mutual Funds (Invesco International Mutual Funds) on 4 December 2024, decreased its holding of voting rights attached to shares and voting rights in ChemoMetec A/S to below 5%, and that the holding...
Nasdaq GlobeNewswire
09/12/2024

Major shareholder announcement – Invesco Ltd.

ANNOUNCEMENT NO. 286 9 December 2024Major shareholder announcementMajor shareholder announcement – Invesco Ltd. Pursuant to Section 30 of the Capital Markets Act, it is hereby announced that Invesco Ltd. has informed ChemoMetec A/S that Invesco Ltd. on 4 December 2024, decreased its holding of voting rights attached to shares and voting rights in ChemoMetec A/S to below 5%, and that the holding thus is below the 5 per cent limit in section 38 of the Capital Markets Act...
Nasdaq GlobeNewswire
09/12/2024

Endo Receives U.S. FDA Approval of Manufacturing Facility in Indore, India

The Indore facility is designed specifically for aseptic manufacturing of sterile injectable products—a difficult and highly specialized production capability. The site is expected to eventually produce medicines in syringes, in addition to vials. The Indore facility is designed specifically for aseptic manufacturing of sterile injectable products—a difficult and highly specialized production capability. The site is expected to eventually produce medicines in syringes, in addition to vials...
PR Newswire
09/12/2024

AiViva Biopharma Receives FDA Clearance to Administer AIV001 in Facial Skin by…

AIV001 is currently in development for evaluation in Superficial and Nodular Superficial Basal Cell Carcinoma (sBCC and nBCC) COSA MESA, Calif., Dec.09, 2024(GLOBE NEWSWIRE) -- AiViva Biopharma Inc., a clinical-stage biotechnology company, announced the receipt of FDA clearance for testing AIV001 (axitinib) by intradermal injection with their formulation in facial skin. AIV001 is a pan-tyrosine kinase inhibitor in a proprietary formulation, designed for prolonged drug release. This FDA...
Nasdaq GlobeNewswire
09/12/2024

Lorena Cosmetics Holdings SPV Announces Acquisition and Re-Launch of The Harley…

Over half of the re-opened sk:n clinics have benefitted from moving to upgraded premises within existing Optical Express clinics, all of which have full Care Quality Commission (CQC), Healthcare Improvement Scotland (HIS), or Healthcare Inspectorate Wales (HIW) registrations which allow for the delivery of advanced treatments and surgical procedures. Lorena Cosmetics plan to continue launching sk:n and THMG services in further locations throughout the UK in 2025. Under Lorena's leadership and…
PR Newswire
09/12/2024

Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce Validation of…

The variation application is supported by a revised Population-PK model and new exposure-response analyses and by the clinical data on pegunigalsidase alfa 2 mg/kg E4W from the completed Phase 3 study PB-102-F50 (BRIGHT) and its ongoing extension study CLI-06657AA1-03 (formerly known as PB-102-F51), that have investigated the 2 mg/kg every four weeks dosing regimen in adult patients with Fabry disease who were previously treated with agalsidase-alfa or -beta administered every two weeks. Results…
PR Newswire
09/12/2024

Zentiva completes voluntary public purchase offer for APONTIS PHARMA AG

Zentiva and APONTIS PHARMA have agreed in the investment agreement that APONTIS PHARMA's management board will, to the extent permitted by law and subject to its fiduciary duties, terminate the inclusion of the APONTIS PHARMA shares in the trading on the open market (Freiverkehr) immediately following the settlement of the offer. A separate delisting offer will not be required. Zentiva and APONTIS PHARMA have agreed in the investment agreement that APONTIS PHARMA's management board will, to…
PR Newswire
09/12/2024

North Six unveils new experiential agency division

North Six is part of Together Group, a curated collective of creative consultancies, marketing, technology and production studios crafting the future of luxury and lifestyle. North Six is part of Together Group, a curated collective of creative consultancies, marketing, technology and production studios crafting the future of luxury and lifestyle. The new agency reflects significant growth in experiential marketing at North Six. "Having worked with the world's leading brands and creative...
PR Newswire
09/12/2024
Altri  Comunicati